FI943295A0 - Piliostigma thonningii -uutteet, niiden käyttö ja Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit niitä sisältävät formuloinnit - Google Patents

Piliostigma thonningii -uutteet, niiden käyttö ja Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit niitä sisältävät formuloinnit

Info

Publication number
FI943295A0
FI943295A0 FI943295A FI943295A FI943295A0 FI 943295 A0 FI943295 A0 FI 943295A0 FI 943295 A FI943295 A FI 943295A FI 943295 A FI943295 A FI 943295A FI 943295 A0 FI943295 A0 FI 943295A0
Authority
FI
Finland
Prior art keywords
formulations containing
extract
thonningii
despiliostigma
piliostigma
Prior art date
Application number
FI943295A
Other languages
English (en)
Swedish (sv)
Other versions
FI943295A (fi
Inventor
Ezio Mombardelli
Paolo Morazzoni
Giuseppe Mustich
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of FI943295A0 publication Critical patent/FI943295A0/fi
Publication of FI943295A publication Critical patent/FI943295A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI943295A 1994-06-01 1994-07-11 Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit FI943295A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941135A IT1269880B (it) 1994-06-01 1994-06-01 Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono

Publications (2)

Publication Number Publication Date
FI943295A0 true FI943295A0 (fi) 1994-07-11
FI943295A FI943295A (fi) 1995-12-02

Family

ID=11369029

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943295A FI943295A (fi) 1994-06-01 1994-07-11 Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit

Country Status (15)

Country Link
US (1) US5635185A (fi)
EP (1) EP0685235B1 (fi)
JP (1) JPH07330788A (fi)
KR (1) KR100235685B1 (fi)
AT (1) ATE189604T1 (fi)
AU (1) AU684781B2 (fi)
CA (1) CA2127762A1 (fi)
DE (2) DE69422980T2 (fi)
DK (1) DK0685235T3 (fi)
ES (1) ES2081782T3 (fi)
FI (1) FI943295A (fi)
GR (2) GR960300005T1 (fi)
HK (1) HK1012567A1 (fi)
IT (1) IT1269880B (fi)
PT (1) PT685235E (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003026636A (ja) * 2001-07-10 2003-01-29 Gekkeikan Sake Co Ltd 脂質代謝系酵素を阻害するチロゾール誘導体
CN108619178B (zh) * 2018-06-08 2021-04-09 临沂大学 一种具有抗病毒作用的忍冬藤菇提取物及其制备方法和应用

Also Published As

Publication number Publication date
CA2127762A1 (en) 1995-12-02
ITMI941135A1 (it) 1995-12-01
DE685235T1 (de) 1996-10-10
JPH07330788A (ja) 1995-12-19
ITMI941135A0 (it) 1994-06-01
GR3032621T3 (en) 2000-05-31
DE69422980D1 (de) 2000-03-16
ES2081782T1 (es) 1996-03-16
AU684781B2 (en) 1998-01-08
EP0685235B1 (en) 2000-02-09
IT1269880B (it) 1997-04-15
ES2081782T3 (es) 2000-07-01
US5635185A (en) 1997-06-03
HK1012567A1 (en) 1999-08-06
FI943295A (fi) 1995-12-02
PT685235E (pt) 2000-05-31
KR960000244A (ko) 1996-01-25
ATE189604T1 (de) 2000-02-15
KR100235685B1 (ko) 2000-02-01
GR960300005T1 (en) 1996-02-29
DE69422980T2 (de) 2000-08-17
AU6751794A (en) 1996-01-04
DK0685235T3 (da) 2000-06-19
EP0685235A1 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
EA199901031A1 (ru) Производные бензимидазола
MY107843A (en) Anti-viral compounds.
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
BR9303469A (pt) Conjugado de interferon,composto,processo de preparacao de um conjugado de interferon,use e composicoes farmaceuticas
FI904445A0 (fi) Antivirala foereningar.
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
ATE219366T1 (de) Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
DK0973735T3 (da) Polyaromatiske antivirale præparater
CA2051289A1 (en) Viral mediated destruction of neoplastic cells
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
PT777669E (pt) Utilizacao de succinato de 4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-ciclopenteno-1-metanol como agente antiviral
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
ATE152717T1 (de) Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen
MX9301922A (es) Composiciones para el tratamiento de infeccion y enfermedad ocasionadas por el virus de hepatitis b (hbv).
FI943295A0 (fi) Piliostigma thonningii -uutteet, niiden käyttö ja Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit niitä sisältävät formuloinnit
MC1930A1 (fr) Produit antiviral
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
GR3017335T3 (en) Oligophosphates with antiviral activity.
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
TW217986B (en) Compositions for the treatment of infection and disease caused by HBV